BLVRA

BLVRA

Target · Oxidoreductase

BLVRA Biliverdin reductase A · BVRA

BLVRA (biliverdin reductase A, also known as BVRA, BVRalpha or BLVR) is a cytosolic oxidoreductase that converts biliverdin IXalpha to bilirubin. It uses NADH or NADPH as cofactor and belongs to the biliverdin reductase family. Browse Assay Genie's current range of BLVRA research reagents below, or read on for the biology behind the target.

Cytosolic enzymeBiliverdin to bilirubinLinked to hyperbiliverdinemia
296 aa
Protein length
~33 kDa
Molecular weight
7p13
Gene locus
EC 1.3.1.24
Enzyme class
Target information

What is BLVRA (biliverdin reductase A)?

BLVRA catalyses the reduction of the gamma-methene bridge of the open tetrapyrrole biliverdin IXalpha, producing bilirubin. The reaction is coupled to oxidation of an NADH or NADPH cofactor. The enzyme is specific for the IXalpha isomer and does not reduce bilirubin IXbeta.

Cofactor choice depends on pH. NADH is used in the acidic range (pH 6 to 6.9), while NADPH is used in the alkaline range (pH 8.5 to 8.7). NADPH is considered the probable reactant in biological systems. The protein is found in the cytosol, and it is the target of choice for work on this step of tetrapyrrole metabolism, whether through a BLVRA antibody, a BLVRA ELISA kit or recombinant BLVRA protein.

The BLVRA gene encodes a member of the biliverdin reductase family, which catalyse the conversion of biliverdin to bilirubin in the presence of NADPH or NADH. In classification terms, the protein belongs to the Gfo/Idh/MocA family, biliverdin reductase subfamily, and HGNC places it in the Gfo/Idh/MocA-like oxidoreductase domain containing group. Alternatively spliced transcript variants have been reported. Mutations in the gene are associated with hyperbiliverdinemia. Orthologues are designated Blvra in both mouse and rat.

Tetrapyrrole metabolism

BLVRA performs the reduction of biliverdin IXalpha to bilirubin, making it a central enzyme for studying this open tetrapyrrole conversion.

Cofactor and pH dependence

The enzyme uses NADH at acidic pH and NADPH at alkaline pH, which makes it a useful model for cofactor preference in oxidoreductases.

Hyperbiliverdinemia research

Mutations in the BLVRA gene are associated with hyperbiliverdinemia, linking the protein to disorders of biliverdin handling.

Oxidoreductase family studies

As a Gfo/Idh/MocA family member of the biliverdin reductase subfamily, BLVRA supports comparative work on this oxidoreductase group.

Background

BLVRA frequently asked questions

What does BLVRA do?

BLVRA reduces the gamma-methene bridge of biliverdin IXalpha to form bilirubin, oxidising NADH or NADPH in the process. NADH is used at acidic pH and NADPH at alkaline pH, with NADPH the probable reactant in biological systems. It does not reduce bilirubin IXbeta.

What other names is BLVRA known by?

BLVRA is the HGNC symbol for biliverdin reductase A. It is also called BVRA, BVRalpha and BLVR in the literature. NCBI Gene reports that alternatively spliced transcript variants exist for this gene, so more than one transcript may be described.

Is BLVRA conserved, and is it linked to disease?

Mouse and rat both carry a Blvra orthologue. In humans, mutations in the BLVRA gene are associated with hyperbiliverdinemia. Check the datasheet of any product for its validated reactivity before using it in a non-human species.

Explore

Related targets

Other biliverdin reductase, haem metabolism and oxidoreductase targets that may be of interest alongside BLVRA.

Gene and protein annotations from HGNC, NCBI Gene and UniProt P53004; product specifications from Assay Genie datasheets.

BLVRA Product listing